RESEARCH
Challenge:
Lack of Quality Studies
Well-conducted clinical research is urgently needed to provide quality data to financial and policy decision makers. There are dozens of psychedelic compounds that have been used for centuries with excellent safety profiles based on historical data, and have early data suggesting potential efficacy for mental health conditions.
OMC Solution:
Quality Clinical Research
OMC investigators have been investigators in the MAPS MDMA studies, as well as investigator-initiated psilocybin studies at UCSF and community clinical research sites. OMC currently is participating in the MAPS x- (TBD). OMC intends to study outcomes associated with its clinical services as pilot data for future clinical research. OMC plans to apply for other investigator-initiated research grants.